Pharmaceutical Sales Force Effectiveness Strategies Evaluating evolving sales models advanced technology for a customer centric approach

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Purdue Pharma L.P.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Purdue Pharma L.P.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • by ICD Research
  • May 2012
  • 17 pages

Synopsis ICD Research's "Purdue Pharma L.P.: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and ...

Industries: Pharmaceutical | Countries: United States

Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study

Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • May 2012
  • 164 pages

Anesthesia is a condition in which sensation is totally or partially blocked. This enables the patients to undergo medical procedures and surgery. Based on the applications (type of surgery or medical procedure) anesthetic drugs are broadly categorized into two types; i.e. local anesthetic drugs and ...

Industries: Drug and Medication | Countries: United States

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 46 pages

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge Summary GBI Research, the leading business intelligence provider, has released its latest research, ?Patient Perspectives - Patient Reported Outcomes Drive Drug Development, ...

Industries: Drug Discovery and Development | Countries: United States

Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • by ICD Research
  • May 2012
  • 45 pages

Synopsis ICD Research's "Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, ...

Industries: Pharmacies and Drug Stores | Countries: United States, Australia, Mexico, Israel

CVS Caremark Corporation: Retailing Company Profile, SWOT & Financial Report

CVS Caremark Corporation: Retailing Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • by Canadean Ltd
  • May 2012
  • 52 pages

Synopsis Canadean's "CVS Caremark Corporation: Retailing Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information ...

Industries: Pharmacies and Drug Stores | Countries: United States

Drug Discovery and Development in United States: BioMarin Pharmaceutical Inc. ? Product Pipeline Review - H2 2011

Drug Discovery and Development in United States: BioMarin Pharmaceutical Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 96 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the BioMarin Pharmaceutical Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

Industries: Pharmaceutical | Countries: United States, World, Ireland

Drug Discovery and Development Industry: Celldex Therapeutics, Inc. ? Product Pipeline Review - H2 2011

Drug Discovery and Development Industry: Celldex Therapeutics, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 82 pages

- Product Pipeline Review - H2 2011? provides a detailed overview on the Celldex Therapeutics, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

Industries: Therapy | Countries: United States

Drug and Medication in United States: BTG plc - Product Pipeline Review - H2 2011

Drug and Medication in United States: BTG plc - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 120 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, BTG plc's corporate website, SEC filings, investo ...

Industries: Drug Delivery Technology | Countries: United States, World

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

Drug and Medication in United States: CSL Limited - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 104 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, CSL Limited's corporate website, SEC filings, investo ...

Industries: Therapy | Countries: United States, World

Drug Discovery and Development in Russian Federation: CEL-SCI Corporation - Product Pipeline Review - H2 2011

Drug Discovery and Development in Russian Federation: CEL-SCI Corporation - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 82 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, CEL-SCI Corporation's corporate website, SEC filings, ...

Industries: Therapy | Countries: World, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 213 49 04

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.